Mazor Robotics reported a net loss for the six months end along with second quarter financials.
Spinal Tech
Bacterin purchased outstanding common stock of X-spine Systems to create a new company, Xtant Medical.
Second quarter net sales dropped 1 percent for DJO Global.
The Boston Business Journal interviewed InVivo Therapeutics' CEO Mark Perrin about how his company plans to take the spine injury market by storm.
Maryland Brain & Spine will now be Maryland Brain, Spine and Pain. The pain management company is now also offering new treatment techniques and more online resources for patients.
Advertisement
Bacterin, developer of bone graft material, has priced $65 million aggregate principle amount of convertible senior unsecured notes due 2021.
Amedica, a biomaterial company, expects to report second quarter 2015 revenue between $4.7 million and $4.9 million. The company also received an answer from the FDA about its Valeo C Interbody with CsC Osteo-Conductive Scaffolding.
The global sports medicine market is expected to grow rapidly in the near future, according to a Market Research Store report.
Materialise entered into an agreement with Lima Corporate.
SeaSpine added two leaders to its management team.